Table 6.
Property investigated | Author/year | Metal | Study design | Property variations | Findings | |||||
---|---|---|---|---|---|---|---|---|---|---|
Size | de Haar et al. 2006 | Ti | F BALB/cANNCrl mouse | Fine TiO2: 250 nm, 6.6 m2/g | Exposure to equal mass doses of fine and ultrafine TiO2 resulted in | |||||
Ovalbumin, 200 μg intranasal | Ultrafine TiO2: 29.0 nm, 49.8 m2/g | increased TH2 cytokines and serum OVA-specific IgE and IgGI only | ||||||||
in animals exposed to ultrafine TiO2 | ||||||||||
Yoshida et al. 2011 | Si | F BALB/c mouse, Ovalbumin | Amorphous silica | Smaller particles induced higher levels of OVA-specific IgE, IgG, and | ||||||
Intranasal: 10, 50, or 250 μg/ mouse x3 | 30, 70, 300, or 1000 nm | IgG1. Splenocytes from mice exposed to the smallest particle pro- | ||||||||
duced higher levels of TH2 cytokines than other groups. | ||||||||||
Liu et al. 2010 | Ti | Rats, Intratracheal instillation | 5 or 200 nm TiO2 | Decreased chemotactic ability, expression of Fc receptors/MHC II by | ||||||
0.5, 5, or 50 μg/mL | alveolar macrophages. Phagocytic function was increased at low | |||||||||
doses and decreased at high doses | ||||||||||
Chang et al. 2014 | Ti | M Sprague Dawley rat | 21 nm TiO2NP: 80% anatase, 20% rutile, | Increased macrophage accumulation and alteration of TH1/TH2 status | ||||||
Intratracheal instillation: x2, x4 w | 1–2 μm TiO2: anatase | |||||||||
0.5, 4, 32 mg/kg | ||||||||||
Ban et al. 2013 | Fe | F BALB/c mouse, Ovalbumin | Submicron Fe2O3: 147±48nm, 6 m2/g | High and medium doses of both Fe particles caused decreases in | ||||||
Intratracheal instillation: | Fe2O3NP: 35±14nm, 39 m2/g | eosinophil influx and OVA-specific IgE levels. However, at the low | ||||||||
4x (100, 250, or 500 μg/mouse) | dose, submicron particles had no effect on allergy, whereas nano- | |||||||||
particles had an adjuvant effect on the TH2 response to OVA | ||||||||||
SA | Rossi et al. 2010 | Ti | F BALB/c/Sca mouse, Ovalbumin | Rutile TiO2NP: <5 μm, 2 m2/g | Allergic pulmonary inflammation was dramatically suppressed in asth- | |||||
Inhalation: 10±2mg/m3 × 12 | Rutile TiO2NP: 10 × 40 nm, 132 m2/g | matic mice exposed to either size TiO2. Leukocyte number, cyto- | ||||||||
kines, chemokines, and antibodies were significantly decreased. | ||||||||||
Parketal. 2015 | Si | F BALB/c mouse, Ovalbumin | Spherical SiNP: 12.7 m2/g | Acute SiNP exposure induced significant airway inflammation and | ||||||
Intranasal inoculation | Mesoporous SiNP: 70.6 m2/g | AHR. Spherical SiNPs induced the greatest degree of exacerbation | ||||||||
PEGylated SiNP: 12.7 m2/g | of allergic effects in the OVA model | |||||||||
Han et al. 2016 | Si | F BALB/c mouse | Spherical SiNP: 12.7 m2/g, 119.6nm | Sensitized mice exposed to S-SiNP and M-SiNP exhibited elevated | ||||||
Ovalbumin | Mesoporous SiNP: 70.6 m2/g, 100.5 nm | AHR over controls. M-SiNPs induced the greatest degree adjuvan- | ||||||||
Intranasal inoculation: 10 mg/kg 6x | PEGylated SiNP: 12.7 m2/g, 439.1 nm | ticity, whereas PEG-SiNP caused the least toxic effects | ||||||||
MOD | CRG Seydoux et al. 2016 | Au | F BALB/c mouse | 90 nm AuNP: | APCs preferentially took up cationic AuNPs, causing upregulation of | |||||
AuNP intranasal instillation: 10 μg | NH2-PVA, 7.2 mV | co-stimulatory molecules. Positive AuNPs enhanced OVA-specific | ||||||||
COOH-PVA 8.2 mV | CD4+ T-cell stimulation in the lung draining lymph nodes | |||||||||
Marzaioli et al. 2014 | Si | F BALB/c mouse, Ovalbumin | Amorphous SiO2NP 15 nm: | Uncoated SiO2NPs induced proinflammatory and immunomodulatory | ||||||
Intratracheal instillation: 50 μg | Uncoated 38 mV, PEGylated 26 mV, | effects with increases in lung inflammatory cells, TH2 cytokines. | ||||||||
Phosphate-coated 43 mV, Amino-coated 0 mV | Amino and phosphate surface modifications mitigated these | |||||||||
effects, whereas PEG coating did not. | ||||||||||
Omlor et al. 2017 | Au | F BALB/c mouse, Ovalbumin | 5 nm AuNP, PEGylated or citrated | Asthmatic condition increased nanoparticle uptake. Systemic uptake is | ||||||
Intranasal instillation | higher for PEGylated AuNP compared to citrated AuNPs, but both | |||||||||
inhibited inflammatory infiltrates and AHR, wherein inhibition was | ||||||||||
more significant following exposure to citrated AuNPS | ||||||||||
Vennemann | Zr | F Wistar rat | APTS, TODS, PGA, or acrylic acid coated | Surface coating had minimal effects on inflammation in the lungs of | ||||||
et al. 2017 | Intratracheal instillation | 9–1 Onm ZrO2NPs | rats, but had significant effects on allergic response. | |||||||
Size MOD | Alessandrini | Ag | F BALB/c mice, Ovalbumin | PVP-coated AgNP: 97 nm, 6.2 m2/g, 7mV | Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in | |||||
et al. 2017 | Intratracheal instillation: 1–50 μg | PVP-coated AgNP: 134nm, 4.5 m2/g, 7mV | sensitized mice. Lung microbiome was altered dependent | |||||||
Citrate-AgNP: 20 nm, 30 m2/g, 45 mV | on coating. | |||||||||
Seiffert et al. 2015 | Ag | Brown Norway and Sprague-Dawley rats | PVP-coated AgNP: 20 or iiOnm | Smaller AgNPs increased AHR on d 1, which persisted to d 7 for the | ||||||
Intratracheal instillation: 0.1 mg/kg | Citrate-capped AgNP: 20 or iiOnm | citrate AgNPs only. 20 nm AgNP was more pro-inflammatory but | ||||||||
little difference between different surface coatings | ||||||||||
CRY Horie et al. 2015 | Zn | F C57BL/6N mouse, Ovalbumin | Rutile TiO2, AI(OH)3 surf: 30–50 nm 37.1 m2/g | Serum total and OVA IgE, IgG1 increased in mice treated with the | ||||||
Ti | Pharyngeal aspiration: 50 μg | ZnO: 21 nm, 49.6 m2/g | uncoated ZnO particle. However, ZnCI2 did not produce similar | |||||||
Si | ZnO, SiO2 Surface: 25 nm, unknown SA, ZnCI2 | exacerbations. TiO2 and SiO2 did not affect OVA-lgE or IgG levels. | ||||||||
Amorphous SiO2: 7nm 300 m2/g, 34 nm 80 m2/g | ||||||||||
SA | Sandberg | Si | LPS-primed RAW264.7 mouse macrophages, pri- | 64 nm Si, 650cm2/mg | Non-crystalline SiO2 particles in both nano and micron size ranges | |||||
et al. 2012 | mary rat lung macrophages | 369 nm Si, 90 cm2/mg | induced IL-1β release from LPS-primed macrophages following | |||||||
0, 50, 100, 250, 500 μg/mL, 6h | ~20nm Fumed Si (aerosol), 1880cm2/mg 500nm-10 μm Fused Si (suprasil), 23cm2/mg | uptake, phagosomal leakage, and activation of the NALP3 inflam- | ||||||||
masome. Particle surface area, reactivity, and uptake all influenced | ||||||||||
the degree of mediator release by cells | ||||||||||
Vandebriel | Ti | F BALB/c mouse, Ovalbumin | Uncoated TiO2NP: | Rutile TiO2NP caused the greatest increase in OVA-specific serum IgE | ||||||
et al. 2018 | Intranasal exposure: 120 μg TiO2 | 10–30 nm rutile or 10–25 nm anatase | and IgGI. Neutrophils recruited by rutile, but not anatase | |||||||
SOL Jeong et al. 2015 | Co | F Rat, Intratracheal Instillation | CoO: 65.4± 2.8 nm, 92.65% solubility | Soluble CoNP induced eosinophilic inflammation, whereas insoluble | ||||||
80, 200, 800 μg/mL @ 0.5 mL | Co3O4: 20.2 ± 0.4 nm, 11.46% solubility | CoONP induced neutrophilic inflammation | ||||||||
Cho et al. 2011 | Zn | F Wistar rat | 10.7±0.7nm ZnONP 50 or 150cm2/rat | ZnONP induced eosinophilia, proliferation of airway epithelial cells, | ||||||
Intratracheal instillation | Zn2+ ions 92.5 μg/rat | goblet cell hyperplasia, and increased IgE levels, and decreased | ||||||||
IgA- findings which were also seen following instillation of Zn ions |
Summary of study design and major findings from studies comparing the effects of various physicochemical properties of metal nanomaterials on respiratory allergy grouped by study property of interest. Properties of interest: size, CRY (crystallinity), MOR (morphology), MOD (surface modification), CRG (surface charge), and SA (surface area), and SOL (solubility). Reported particle size (nm), specific surface area (m2/g), zeta potential (mV), pore volume (cm3/g), in vitro dose concentration (mg/mL). AHR: airway hyperreactivity; APC: antigen-presenting cell; APTS: aminopropylsilane modification; DC-SIGN: dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin; MDDC: monocyte-derived dendritic cell; MHC: major histocompatibility complex; OVA: ovalbumin; PDI: polydispersity index; PEG: poly(ethylene glycol) modification; PGA: poly(lactic-coglycolicacid) modification; PVA: PVP polyvinylpyrrolidone modification; ROS: reactive oxygen species; TODS: tetraoxidecanoic acid modification